Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Abbott |
---|---|
Information provided by: | Abbott |
ClinicalTrials.gov Identifier: | NCT00002366 |
To evaluate the safety and anti-Kaposi's sarcoma activity of ritonavir.
Condition | Intervention | Phase |
---|---|---|
Sarcoma, Kaposi HIV Infections |
Drug: Ritonavir |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Safety Study |
Official Title: | A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Concurrent Treatment:
Allowed:
Localized radiotherapy will be allowed for lesions which will not be used as indicator or biopsy lesions.
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
Concurrent Medication:
Excluded:
Concurrent Treatment:
Excluded:
Radiotherapy for Kaposi's sarcoma.
Patients with any of the following prior conditions are excluded:
Prior Medication:
Excluded:
Risk Behavior:
Excluded:
Active substance abuse.
Study ID Numbers: | 245C, M95-320 |
Study First Received: | November 2, 1999 |
Last Updated: | February 19, 2009 |
ClinicalTrials.gov Identifier: | NCT00002366 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Skin Neoplasms Sarcoma, Kaposi Acquired Immunodeficiency Syndrome HIV Protease Inhibitors Ritonavir |
Anti-Infective Agents HIV Protease Inhibitors Sexually Transmitted Diseases, Viral Anti-HIV Agents Acquired Immunodeficiency Syndrome Sarcoma, Kaposi Skin Neoplasms Antiviral Agents Immunologic Deficiency Syndromes Protease Inhibitors Kaposi Sarcoma Herpesviridae Infections |
Virus Diseases Neoplasms, Connective and Soft Tissue Soft Tissue Sarcomas Malignant Mesenchymal Tumor Anti-Retroviral Agents Ritonavir HIV Infections Sexually Transmitted Diseases Sarcoma DNA Virus Infections Retroviridae Infections |
Anti-Infective Agents Sexually Transmitted Diseases, Viral Slow Virus Diseases Molecular Mechanisms of Pharmacological Action Infection Neoplasms, Connective and Soft Tissue Anti-Retroviral Agents Therapeutic Uses Neoplasms, Vascular Tissue Retroviridae Infections RNA Virus Infections HIV Protease Inhibitors Anti-HIV Agents Neoplasms by Histologic Type Immune System Diseases |
Sarcoma, Kaposi Acquired Immunodeficiency Syndrome Enzyme Inhibitors Antiviral Agents Pharmacologic Actions Immunologic Deficiency Syndromes Herpesviridae Infections Protease Inhibitors Virus Diseases Neoplasms HIV Infections Ritonavir Sexually Transmitted Diseases Lentivirus Infections Sarcoma |